Prestige News

Total 78
Number Thumbnail Title Author Date Votes Views
38 PPrestige Biopharma Secures European Patent for Pancreatic Cancer Antibody PBP1510
김** | 2025.08.01 | Votes 0 | Views 1813
김** 2025.08.01 0 1813
37 Prestige Biopharma IDC Files Patent for Anti-CTHRC1 Antibody Combination Therapy for Solid Tumors
we******** | 2025.07.28 | Votes 0 | Views 1267
we******** 2025.07.28 0 1267
36 Prestige Biopharma IDC Hosts Regional R&D Engagement Tour with BISTEP and Civic Groups
we******** | 2025.07.16 | Votes 0 | Views 1186
we******** 2025.07.16 0 1186
35 Prestige Biopharma IDC Shares Antibody-Based Drug Research with KAIST Professors
김** | 2025.07.10 | Votes 0 | Views 1347
김** 2025.07.10 0 1347
34 Prestige Biopharma Highlights PBP1510 Clinical Progress at ASCO 2025
we******** | 2025.06.04 | Votes 0 | Views 2499
we******** 2025.06.04 0 2499
33 Prestige Biopharma Signs 31 European Licensing and Supply Agreement with Teva for Tuznue®
we******** | 2025.05.26 | Votes 0 | Views 1831
we******** 2025.05.26 0 1831
32 Prestige Biopharma Publishes Preclinical Study of Biosimilar Tuznue® in SCI Journal Drug in R&D
we******** | 2025.04.16 | Votes 0 | Views 1326
we******** 2025.04.16 0 1326
31 Busan-Jinhae Free Economic Zone Commissioner Visits Prestige Biopharma IDC to Discuss Biopharma Industry Collaboration
we******** | 2025.04.03 | Votes 0 | Views 1214
we******** 2025.04.03 0 1214
30 Prestige Biopharma to Present Preliminary Phase 1/2a Results of Pancreatic Cancer Antibody PBP1510 at AACR 2025
we******** | 2025.04.01 | Votes 0 | Views 1846
we******** 2025.04.01 0 1846
29 Prestige Biopharma Files Patent for Early Pancreatic Cancer Diagnostic Technology
we******** | 2025.01.22 | Votes 0 | Views 1317
we******** 2025.01.22 0 1317